Modelling human protein interaction networks as metric spaces has potential in disease research and drug target discovery

BMC Systems Biology

Volumn 8, Issue 1, 2014, Pages

  Fadhal, Emad ^a   Mwambene, Eric C ^a   Gamieldien, Junaid ^a  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

Core periphery structure; Disease genes; Drug discovery; Essential proteins; Metric spaces; Protein interaction networks; Topological centrality

Indexed keywords

TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BIOLOGICAL MODEL; BIOLOGY; DRUG DEVELOPMENT; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULARLY TARGETED THERAPY; NEOPLASM; ONCOGENE; PROTEIN PROTEIN INTERACTION;

COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; HUMANS; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; NEOPLASMS; ONCOGENES; PROTEIN INTERACTION MAPS; TUMOR SUPPRESSOR PROTEINS;

EID: 84902051575     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-8-68     Document Type: Article

References (42)

1. Ideker T, Krogan NJ. Differential network biology. Mol Syst Biol 2012, 8(565):565. [http://www.nature.com/doifinder/10.1038/msb.2011.99].
2. Souiai O, Becker E, Prieto C, Benkahla A, De Las Rivas J, Brun C. Functional integrative levels in the human interactome recapitulate organ organization. PLoS ONE 2011, 6(7):10. [http://dx.plos.org/10.1371/journal.pone.0022051].
3. Sear R. Interactions in protein solutions. Curr Opin Colloid Interface Sci 2006, 11:35-39. [http://linkinghub.elsevier.com/retrieve/pii/S1359029405000610].
4. Park J, Lappe M, Teichmann SA. Mapping protein family interactions: intramolecular and intermolecular protein family interaction repertoires in the PDB and yeast. J Mol Biol 2001, 307(3):929-938. [http://www.ncbi.nlm.nih.gov/pubmed/11273711].
5. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature 1999, 402(6761 Suppl):C47-52. [http://www.ncbi.nlm.nih.gov/pubmed/10591225].
6. Ouzounis CA, Karp PD. Global properties of the metabolic map of Escherichia coli. Genome Res 2000, 10(4):568-576. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=310896&tool=pmcentrez&rendertype=abstract].
7. McAdams HH, Arkin A. Gene regulation: Towards a circuit engineering discipline. Curr Biol 2000, 10(8):R318-R320. [http://linkinghub.elsevier.com/retrieve/pii/S0960982200004401].
8. Elowitz MB, Leibler S. A synthetic oscillatory network of transcriptional regulators. Nature 2000, 403(6767):335-338. [http://dx.doi.org/10.1038/35002125].
9. Savageau MA. Design principles for elementary gene circuits: Elements, methods, and examples. Chaos Woodbury Ny 2001, 11:142-159. [http://www.ncbi.nlm.nih.gov/pubmed/12779449].
10. Bolouri H, Davidson EH. Modeling transcriptional regulatory networks. BioEssays 2002, 24(12):1118-1129. [http://www.ncbi.nlm.nih.gov/pubmed/12447977].
11. Hasty J, McMillen D, Isaacs F, Collins JJ. Computational studies of gene regulatory networks: in numero molecular biology. Nat Rev Genet 2001, 2:268-279.
12. Guet CC, Elowitz MB, Hsing W, Leibler S. Combinatorial synthesis of genetic networks. Science 2002, 296(5572):1466-1470. [http://www.ncbi.nlm.nih.gov/pubmed/12029133].
13. Newman MEJ. The structure and function of complex networks. SIAM Rev 2003, 45(2):58. [http://arxiv.org/abs/cond-mat/0303516].
14. Spirin V, Mirny LA. Protein complexes and functional modules in molecular networks. Proc Nat Acad Sci USA 2003, 100(21):12123-12128. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=218723&tool=pmcentrez&rendertype=abstract].
15. Zaki N, Berengueres J, Efimov D. Detection of protein complexes using a protein ranking algorithm. Proteins 2012, 80(10):2459-68. [http://www.ncbi.nlm.nih.gov/pubmed/22685080].
16. Zaki N, Efimov D, Berengueres J. Protein complex detection using interaction reliability assessment and weighted clustering coefficient. BMC Bioinformatics 2013, 14:163. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3680028&tool=pmcentrez&rendertype=abstract].
17. Kar G, Gursoy A, Keskin O. Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol 2009, 5(12):e1000601.
18. Koyutürk M, Szpankowski W, Grama A. Assessing significance of connectivity and conservation in protein interaction networks. J Comput Biol 2007, 14(6):747-764.
19. Sen TZ, Kloczkowski A, Jernigan RL. Functional clustering of yeast proteins from the protein-protein interaction network. BMC Bioinformatics 2006, 7:355. [http://www.biomedcentral.com/1471-2105/12/409].
20. Karimpour-Fard A, Leach SM, Hunter LE, Gill RT. The topology of the bacterial co-conserved protein network and its implications for predicting protein function. BMC Genomics 2008, 9:313. [http://www.ncbi.nlm.nih.gov/pubmed/18590549].
21. Pierre S, Scholich K. Toponomics: studying protein-protein interactions and protein networks in intact tissue. Mol Biosyst 2010, 6(4):641-647. [http://www.ncbi.nlm.nih.gov/pubmed/20237641].
22. Jeong H, Mason S, Barabasi A, Oltvai Z. Lethality and centrality in protein networks. Nature 2001, 411(6833):41-42. [http://www.ncbi.nlm.nih.gov/pubmed/11333967].
23. Zotenko E, Mestre J, O'Leary D, Przytycka T. Why do hubs in the yeast protein interaction network tend to be essential: reexamining the connection between the network topology and essentiality. PLoS Comput Biol 2008, 4(8):e1000140.
24. He X, Zhang J. Why do hubs tend to be essential in protein networks?. PLoS Genet 2006, 2(6):e88.
25. AlvarezHamelin JI, DallAsta L, Barrat A, Vespignani A. k-core decomposition: a tool for the visualization of large scale networks. World Wide Web Internet Web Inform Syst 2005, abs/cs/050. [http://arxiv.org/abs/cs/0504107].
26. Dickerson JE, Zhu A, Robertson DL, Hentges KE. Defining the Role of Essential Genes in Human Disease. PLoS ONE 2011, 6(11):e27368. [http://dx.doi.org/10.1371/journal.pone.0027368].
27. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL. The human disease network. Proc Nat Acad Sci USA 2007, 104(21):8685-8690. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1885563&tool=pmcentrez&rendertype=abstract].
28. Chavali S, Barrenas F, Kanduri K, Benson M. Network properties of human disease genes with pleiotropic effects. BMC Syst Biol 2010, 4:78. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2892460&tool=pmcentrez&rendertype=abstract].
29. Hwang S, Son SW, Kim SC, Kim YJ, Jeong H, Lee D. A protein interaction network associated with asthma. J Theor Biol 2008, 252(4):722-731. [http://www.ncbi.nlm.nih.gov/pubmed/18395227].
30. Vinogradov AE. Modularity of cellular networks shows general center-periphery polarization. Bioinformatics 2008, 24(24):2814-2817. [http://www.ncbi.nlm.nih.gov/pubmed/18953046].
31. Zhu M, Gao L, Li X, Liu Z. Identifying drug-target proteins based on network features. Sci China Series C Life Sci Chin Acad Sci 2009, 52(4):398-404. [http://www.ncbi.nlm.nih.gov/pubmed/19381466].
32. Fadhal E, Gamieldien J, Mwambene EC. Protein interaction networks as metric spaces: a novel perspective on distribution of hubs. BMC Syst Biol 2014, 8:6.
33. Wu G, Feng X, Stein L. A human functional protein interaction network and its application to cancer data analysis. Genome Biol 2010, 11(5):R53.
34. Li L, Tibiche C, Fu C, Kaneko T, Moran MF, Schiller MR, Li SS, Wang E. The human phosphotyrosine signaling network: evolution and hotspots of hijacking in cancer. Genome Res 2012, 22(7):1222-1230.
35. Awan A, Bari H, Yan F, Moksong S, Yang S, Chowdhury S, Cui Q, Yu Z, Purisima EO, Wang E. Regulatory network motifs and hotspots of cancer genes in a mammalian cellular signalling network. IET Syst Biol 2007, 1(5):292-297.
36. Bandyopadhyay S, Chiang CY, Srivastava J, Gersten M, White S, Bell R, Kurschner C, Martin CH, Smoot M, Sahasrabudhe S, Barber DL, Chanda SK, Ideker T. A human MAP kinase interactome. Nat Methods 2010, 7(10):801-5. [http://www.ncbi.nlm.nih.gov/pubmed/20936779].
37. Sawyers C. Targeted cancer therapy. Nature 2004, 432(7015):294-7. [http://www.ncbi.nlm.nih.gov/pubmed/15549090].
38. Pharmaceuticals A, Pharmaceuticals K. Signal transduction as a drug-discovery platform Mapping the key signaling molecules in biochemical pathways will be central. Nature Biotechnol 2000, VOL 18(3):37-39.
39. Schriml LM, Arze C, Nadendla S, Chang YWW, Mazaitis M, Felix V, Feng G, Kibbe WA. Disease Ontology: a backbone for disease semantic integration. Nucleic Acids Res 2012, 40(Database issue):D940-6. [].
40. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. The Cancer genome landscapes. Science New York NY 2013, 339(6127):1546-58. [http://www.ncbi.nlm.nih.gov/pubmed/23539594].
41. Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F, Zhang L, Song Y, Liu X, Zhang J, Han B, Zhang P, Chen Y. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res 2012, 40(Database issue):D1128-36. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3245130&tool=pmcentrez&rendertype=abstract].
42. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010, 38(suppl 1):D355-D360.